1566
Vol. 56, No. 11
Jꢀ8.4, 1.7 Hz, 1H, aromatic), 7.96 (dd, Jꢀ8.4, 1.7 Hz, 1H, aromatic). 13C-
NMR (75.4 MHz, acetone-d6) d: 10.8, 13.9, 107.5, 107.9, 114.3, 117.3,
120.2, 124.0, 124.1, 124.6, 128.8, 129.1, 130.2, 131.5, 132.8, 132.9, 133.0,
145.4, 146.1, 146.9 148.0, 152.7, 152.8, 157.8, 158.5, 158.6, 159.0, 167.5.
6) Abd Allah O. A., II Farmaco, 55, 641—649 (2000).
7) Xie L., Takeuchi Y., Cosentino L. M., Lee K., J. Med. Chem., 42,
2662—2672 (1999).
8) Zhao H., Neamati N., Hong H., Mazumder A., Wang S., Sunder S.,
Milne G. W. A., Pommier Y. Jr., Burke T. R., J. Med. Chem., 40, 242—
249 (1997).
9) Wawzoneck S., “Heterocyclic Compounds,” Vol. 2, ed. by Elderfield
R. C., Wiley, New York, 1951, p. 176.
10) Staunton J., “Comprehensive Organic Chemistry,” Vol. 4, ed. by
Sammes P. G., Pergamon Press, Oxford, 1979, p. 646.
11) Hepworth J. D., “Comprehensive Heterocyclic Chemistry,” Vol. 3, ed.
by Boulton A. J., Mckillop A., Pergamon Press, Oxford, 1984, p. 799.
12) AMICBASE-EssOil, Database on Natural Antimicrobials, Review Sci-
ence, Germany (1999—2002).
13) Pauli A., “Antimicrobial Properties of Catechol Derivatives,” 3rd
World Congress on Allelopathy, Tsukuba, Japan, 2002.
14) Nematollahi D., Habibi D., Rahmati M., Rafiee M., J. Org. Chem., 69,
2637—2640 (2004).
15) Nematollahi D., Rafiee M., Green Chem., 7, 638—644 (2005).
16) Hosseiny Davarani S. S., Nematollahi D., Shamsipur M., Mashkouri
Najafi N., Masoumi L., Ramyar S., J. Org. Chem., 71, 2139—2142
(2006).
17) Nematollahi D., Goodarzi H., J. Org. Chem., 67, 5036—5039 (2002).
18) Nematollahi D., Amani A., Tammari E., J. Org. Chem., 72, 3646—
3651 (2007).
MS (EI): m/z (relative intensity): 300 [M]ꢃ (100), 288 (31), 282 (51), 267
·
(41), 239 (11), 178 (70), 150 (36), 145 (47), 121 (45), 110 (26), 89 (59), 77
(20), 63 (33).
4-(3,4-Dihydroxy-5-methoxyphenylthio)-2H-chromen-2-one
(C16H12O5S) (4c) mp 228—230 °C (dec.). IR (KBr) cmꢁ1: 3438, 3176,
2927, 1673, 1599, 1544, 1505, 1343, 1309, 1239, 1196, 1175, 1107, 952,
843, 824, 762. 1H-NMR (300 MHz, acetone-d6) d: 3.90 (s, 3H, methoxy),
5.61 (s, 1H, C9-H), 6.86 (s, 2H, aromatic), 7.41 (m, Jꢀ8.8 Hz, 2H, aro-
matic), 7.70 (m, Jꢀ8.5 Hz, 1H, aromatic), 7.91 (dd, Jꢀ8.3, 1.6 Hz, 1H, aro-
matic) and 9.2 (broad, about 2H, –OH). 13C-NMR (75.4 MHz, acetone-d6) d:
56.3, 108.0, 111.4, 114.5, 117.2, 117.3, 118.0, 123.9, 124.6, 132.9, 137.4,
147.1, 149.7, 152.7, 158.5, 158.7. MS (EI): m/z (relative intensity): 316
[M]ꢃ (100), 283 (60), 178 (74), 145 (50), 121 (41), 89 (53), 63 (34).
·
4-(4,5-Dihydroxy-2-methylphenylthio)-2H-chromen-2-one
(C16H12O4S) (4d) mp 273—275 °C (dec.). IR (KBr) cmꢁ1: 3344, 1686,
1600, 1546, 1519, 1445, 1414, 1344, 1320, 1270, 1187, 1158, 950, 869,
841, 824,767, 743. 1H-NMR (300 MHz, acetone-d6) d: 2.29 (s, 3H, methyl),
5.41 (s, 1H, C9-H), 7.01 (s, 1H, aromatic), 7.10 (s, 1H, aromatic), 7.44 (m,
Jꢀ8.1 Hz, 2H, aromatic), 7.69 (t, Jꢀ9.2 Hz, 1H, aromatic), 7.94 (d,
Jꢀ8.4 Hz, 1H, aromatic), 8.5 (broad, 2H, –OH). 13C-NMR (75.4 MHz, ace-
tone-d6) d: 19.2, 107.3, 113.4, 117.2, 118.1, 118.7, 123.5, 124.2, 124.6,
132.9, 135,6, 145.0, 148.9, 152.9, 157.5, 158.5. MS (EI): m/z (relative inten-
19) Nematollahi D., Workentin M. S., Tammari E., Chem. Commun., 2006,
1631—1633 (2006).
sity): 300 [M]ꢃ (38), 272 (8), 267 (16), 178 (24), 145 (30), 121 (44), 89
·
20) Nematollahi D., Afkhami A., Tammari E., Shariatmanesh T., Hesari
M., Shojaeifard M., Chem. Commun., 2007, 162—164 (2007).
21) Nematollahi D., Tammari E., J. Org. Chem., 70, 7769—7772 (2005).
22) Golabi S. M., Nematollahi D., J. Electroanal. Chem., 420, 127—134
(1997).
23) Carey F. A., Sundberg R. J., “Advanced Organic Chemistry,” Part A,
4th ed., Kluwer Academic Publishers, New York, 2000, p. 293.
24) Majumdar K. C., Ghosh S. K., Tetrahedron Lett., 43, 2115—2117
(2002).
25) Frisch M. J., Trucks G. W., Schlegel H. B., Scuseria G. E., Robb M.
A., Cheeseman J. R., Zakrzewski V. G., Montgomery J. A., Stratmann
R. E. Jr., Burant J. C., Dapprich S., Millam J. M., Daniels A. D., Kudin
K. N., Strain M. C., Farkas O., Tomasi J., Barone V., Cossi M., Cammi
R., Mennucci B., Pomelli C., Adamo C., Clifford S., Ochterski J., Pe-
tersson G. A., Ayala P. Y., Cui Q., Morokuma K., Malick D. K.,
Rabuck A. D., Raghavachari K., Foresman J. B., Cioslowski J., Ortiz J.
V., Stefanov B. B., Liu G., Liashenko A., Piskorz P., Komaromi I.,
Gomperts R., Martin R. L., Fox D. J., Keith T., Al-Laham M. A., Peng
C. Y., Nanayakkara A., Gonzalez C., Challacombe M., Gill P. M. W.,
Johnson B., Chen W., Wong M. W., Andres J. L., Head-Gordon M.,
Replogle E. S., Pople J. A., GAUSSIAN 98 (Revision A.3) Gaussian
Inc., Pittsburgh, PA, 1998.
(100), 77 (40), 63 (78), 39 (50).
Computational Details DFT (density functional theory) calculations
were carried out using B3LYP/6-31G*//B3LYP/6-31G*, level of theory with
the GAUSSIAN 98 package of programs25) implemented on a Pentium-PC
computer with a 2.6 GHz processor. Initial estimation of the structural
geometry of the compounds 1a, 7 and 4a was obtained by a molecular me-
chanic program PCMODEL (88.0),26) and for further optimization of geom-
etry, we used the PM3 method of the MOPAC 7.0 computer program.27,28)
The GAUSSIAN 98 package of programs were finally used to perform DFT
calculations at the B3LYP/6-31G* level. Energy-minimum molecular
geometries were located by minimizing energy, with respect to all geometri-
cal coordinates without imposing any symmetrical constraints. The nature of
the stationary points for the compounds 1a, 7 and 4a has been fixed by
means of the number of imaginary frequencies. For minimum state struc-
ture, only real frequency values, and in the transition-state, only single imag-
inary frequency values, were accepted.29,30) NBO analysis was then per-
formed at the B3LYP/6-31G* level by the NBO 3.1 program31,32) included in
the GAUSSIAN 98 package of programs.
Acknowledgements Financial support for this work by the Iran Na-
tional Science Foundation (INSF), Tehran, Iran, is gratefully acknowledged.
26) Serena Software, Box 3076, Bloomington, IN, U.S.A.
27) Stewart J. J. P., QCPE 581, Department of Chemistry, Indiana Univer-
sity, Bloomington, IN, U.S.A.
References and Notes
1) Cacic M., Trkovnik M., Cacic F., Has-Schon E., Molecules, 11, 134—
137 (2006).
28) Stewart J. J. P., J. Comput.-Aided Mol. Des., 4, 1—103 (1990).
29) McIver J. W. Jr., Acc. Chem. Res., 7, 72—77 (1974).
30) Ermer O., Tetrahedron, 31, 1849—1854 (1975).
31) Glendening E. D., Reed A. E., Carpener J. E., Weinhold F., NBO Ver-
sion 3.1.
2) Czerpack R., Skolska S., Med. Dosw. Microbiol., 34, 37—50 (1982)
[Chem. Abstr., 98, 50232 (1983)].
3) Jund L., Corse J., King A. S., Bayne H., Mihrag K., Phytochemistry,
10, 2971—2974 (1971).
4) El-Ansary S. L., Aly E. I., Halem M. A., Egypt. J. Pharm. Sci., 33,
379—390 (1992).
5) Reddy Y. D., Somayojulu V. V., J. Ind. Chem. Soc., 58, 599—601
(1981).
32) Reed A. E., Curtiss L. A., Weinhold F., Chem. Rev., 88, 899—926
(1988).